Homozygous COQ7 mutation: a new cause of potentially treatable distal hereditary motor neuropathy
Brain · 2023
DOI: 10.1093/brain/awac453 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, 2023. Verfasst von Arnaud Jacquier und 19 weiteren Autor:innen. Beteiligte Einrichtung: Pathophysiology and Genetics of Neuron and Muscle, CNRS UMR 5261, INSERM U1315, Université Lyon1, Faculté de Médecine Lyon Est, Lyon, France. Hauptthemen laut MEDLINE: Mitochondrial Diseases, Ubiquinone. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Association pour le Développement de la Neurogénétique, Fondation pour la Recherche Médicale, Société Francophone du Nerf Périphérique.
Abstract (Originalsprache)
Distal hereditary motor neuropathy represents a group of motor inherited neuropathies leading to distal weakness. We report a family of two brothers and a sister affected by distal hereditary motor neuropathy in whom a homozygous variant c.3G>T (p.1Met?) was identified in the COQ7 gene. This gene encodes a protein required for coenzyme Q10 biosynthesis, a component of the respiratory chain in mitochondria. Mutations of COQ7 were previously associated with severe multi-organ disorders characterized by early childhood onset and developmental delay. Using patient blood samples and fibroblasts derived from a skin biopsy, we investigated the pathogenicity of the variant of unknown significance c.3G>T (p.1Met?) in the COQ7 gene and the effect of coenzyme Q10 supplementation in vitro. We showed that this variation leads to a severe decrease in COQ7 protein levels in the patient’s fibroblasts, resulting in a decrease in coenzyme Q10 production and in the accumulation of 6-demethoxycoenzyme Q10, the COQ7 substrate. Interestingly, such accumulation was also found in the patient’s plasma. Normal coenzyme Q10 and 6-demethoxycoenzyme Q10 levels were restored in vitro by using the coenzyme Q10 precursor 2,4-dihydroxybenzoic acid, thus bypassing the COQ7 requirement. Coenzyme Q10 biosynthesis deficiency is known to impair the mitochondrial respiratory chain. Seahorse experiments showed that the patient’s cells mainly rely on glycolysis to maintain sufficient ATP production. Consistently, the replacement of glucose by galactose in the culture medium of these cells reduced their proliferation rate. Interestingly, normal proliferation was restored by coenzyme Q10 supplementation of the culture medium, suggesting a therapeutic avenue for these patients. Altogether, we have identified the first example of recessive distal hereditary motor neuropathy caused by a homozygous variation in the COQ7 gene, which should thus be included in the gene panels used to diagnose peripheral inherited neuropathies. Furthermore, 6-demethoxycoenzyme Q10 accumulation in the blood can be used to confirm the pathogenic nature of the mutation. Finally, supplementation with coenzyme Q10 or derivatives should be considered to prevent the progression of COQ7-related peripheral inherited neuropathy in diagnosed patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathophysiology and Genetics of Neuron and Muscle, CNRS UMR 5261, INSERM U1315, Université Lyon1, Faculté de Médecine Lyon Est, Lyon, France.
- Centre de Biotechnologie Cellulaire, CBC Biotec, CHU de Lyon-Hospices Civils de Lyon (HCL) groupement Est, Bron, France.
- Hôpital Neurologique Pierre Wertheimer, Service d'électroneuromyographie et de pathologies neuromusculaires, CHU de Lyon-Hospices Civils de Lyon (HCL) groupement Est, Bron, France.
- Service de Biochimie, CHU de Caen, UMRS 1237 PhIND, Université de Caen, Caen, France.
- Hôpital Henry Gabrielle, Service de Médecine Physique et de Réadaptation, CHU de Lyon-Hospices Civils de Lyon (HCL), Saint-Genis-Laval, France.
- Unité fonctionnelle de neurogénétique moléculaire, CHU de Lyon-Hospices Civils de Lyon (HCL) groupement Est, Bron, France.
ORCID-Profile: Laurent Schaeffer
Förderung
- Association pour le Développement de la Neurogénétique
- Fondation pour la Recherche Médicale
- Société Francophone du Nerf Périphérique
- AFM Téléthon
- equipe FRM
Zitieren
APA
Jacquier, A., Theuriet, J., Fontaine, F., Mosbach, V., Lacoste, N., Ribault, S., Risson, V., Carras, J., Coudert, L., Simonet, T., Latour, P., Stojkovic, T., Piard, J., Cosson, A., Lesca, G., Bouhour, F., Allouche, S., Puccio, H., Pegat, A., & Schaeffer, L. (2023). Homozygous COQ7 mutation: a new cause of potentially treatable distal hereditary motor neuropathy. Brain. https://doi.org/10.1093/brain/awac453
Vancouver
Jacquier A, Theuriet J, Fontaine F, Mosbach V, Lacoste N, Ribault S, et al. Homozygous COQ7 mutation: a new cause of potentially treatable distal hereditary motor neuropathy. Brain. 2023. doi:10.1093/brain/awac453
BibTeX
@article{Jacquier2023,
author = {Jacquier, Arnaud and Theuriet, Julian and Fontaine, Fanny and Mosbach, Valentine and Lacoste, Nicolas and Ribault, Shams and Risson, Valérie and Carras, Julien and Coudert, Laurent and Simonet, Thomas and Latour, Philippe and Stojkovic, Tanya and Piard, Juliette and Cosson, Anne and Lesca, Gaëtan and Bouhour, Françoise and Allouche, Stéphane and Puccio, Hélène and Pegat, Antoine and Schaeffer, Laurent},
title = {Homozygous COQ7 mutation: a new cause of potentially treatable distal hereditary motor neuropathy},
journal = {Brain},
year = {2023},
doi = {10.1093/brain/awac453}
}
EUVIMED